Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the first to market, commercial launch of two novel phospho-tau ...

You might have read and heard a lot of neurological conditions like Alzheimer’s and Parkinson’s, however, there’s another ...

New computer simulations that model every atom of a protein as it folds into its final three-dimensional form support the ...

SkyQuest Technology Consulting published a report, titled, Biomarkers Market - Global Opportunity Analysis and Industry Forecast, 2025-2032", valued at USD 65.36 Billion in 2024. With a projected CAGR ...

Experience the world in its purest form with “Unedited Earth,” a breathtaking 4K ULTRA HD showcase of raw landscapes and ...

Stem cells differentiated into brain and neural organoids may help scientists understand both brain development and ...

The Alzheimer’s Association has launched a new, free app to help those in the early stages of the disease and their loved ...

A new study suggested that not getting enough REM sleep can be an early warning sign of Alzheimer's disease. Here's what a neurologist wants you to know.

The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that slow progression of the disease is drastically improving outcomes for ...

A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.

Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer’s disease than the general population.A retrospective analysis in ...